Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

SG&A (USD, thousands)

R&D (USD, thousands)

D&A (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

EPS - Basic (USD)

EPS - Diluted (USD)

58ea31880651cd6aa60d085791dc268aef99b3fb662a03d96c6d59f2c284945b

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

52ab360fed0606b7fcc23aab1409438694119ed22d1e5ea1b4c44eecb62bedd8

- Painful Diabetic Neuropathy (PDN) Revenue

Total Revenue

58930109eec34241f09a6c12ae20e14f87062ff89fee2fc3cdb04c76de1dae1e

Covered lives for Carelon and Anthem BCBS for PDN (million covered lives)

Total PDN covered lives (million covered lives)

99ac308bfaf517fef51bc5fc8f2064eb52a7efcd2549a0f7a8913e6daa5adce4

29b3b3c53f505115cd8f8dfba0ba9011c1b3fdfe6c194e26a636f6ff41830d67

633e6b3e23589fe54c51a96349396c665755a4e57c3f9947e46fceeae4cab031

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

5ce27c3c9971b3e6c712e7592977cb58bb36324930e5fa072dc65e48bf06beb5

Company not found (NVRO)

Financials